Orange Book product · Generic (ANDA)
ADENOSINE
ADENOSINE
At a glance
Nov 02, 2017
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 02, 2017
8 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
ADENOSINE
Strength
60MG/20ML (3MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
AP
Application
ANDA 205331
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ADENOSINE
- 1995ADENOSCANBrand (NDA)
NDA 020059 · ASTELLAS
- 1989ADENOCARDBrand (NDA)
NDA 019937 · ASTELLAS
- 2018ADENOSINEGeneric (ANDA)
ANDA 205568 · FRESENIUS KABI USA
- 2018ADENOSINEGeneric (ANDA)
ANDA 206778 · GLAND
- 2017ADENOSINEGeneric (ANDA)
ANDA 077897 · FRESENIUS KABI USA
- 2014ADENOSINEGeneric (ANDA)
ANDA 090450 · RISING
- 2014ADENOSINEGeneric (ANDA)
ANDA 202313 · AVET LIFESCIENCES
- 2014ADENOSINEGeneric (ANDA)
ANDA 090212 · MYLAN ASI
- 2014ADENOSINEGeneric (ANDA)
ANDA 203883 · HOSPIRA
- 2014ADENOSINEGeneric (ANDA)
ANDA 078640 · PHARMOBEDIENT
- 2013ADENOSINEGeneric (ANDA)
ANDA 077425 · MEITHEAL
- 2009ADENOSINEGeneric (ANDA)
ANDA 090220 · WOCKHARDT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
